FDA Adverse Event Injury Summary report: N

PROSA SYS W/PROGAV 2.0 A.CONTROL RESERV.

MDR report key: 8407854 · Received March 11, 2019

Report

Report Number
3004721439-2019-00070
Event Type
Injury
Date Received
March 11, 2019
Date of Event
February 26, 2019
Report Date
November 7, 2019
Manufacturer
CHRISTOPH MIETHKE GMBH & CO. KG
Product Code
JXG
PMA / PMN Number
K141687
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

VISUAL INSPECTION NOT PERFORMED. PERMEABILITY TEST NOT PERFORMED. ADJUSTMENT TEST NOT PERFORMED. BRAKING FORCE AND BRAKE FUNCTION TEST NOT PERFORMED. RESULTS THE SHUNT SYSTEM WAS SUBMITTED DRY AND WITH SIGNIFICANT BLOODY RESIDUE. DUE TO THE CONDITION, THE SHUNT SYSTEM WAS RECEIVED IN AND THE NOTED RISK OF INFECTION, WE HAVE DETERMINED THAT THE RISK LEVEL OF THIS SPECIMEN IS TOO GREAT TO ALLOW FOR INSPECTION BY OUR EMPLOYEES. FOR THIS REASON, THE SPECIMEN HAS NOT BEEN INSPECTED AND HAS BEEN RETURNED TO THE SUBMITTING HOSPITAL. WE CAN EXCLUDE A DEFECT AT THE TIME OF RELEASE. THE VALVE MET ALL SPECIFICATIONS OF THE FINAL INSPECTION WHEN RELEASED FROM CHRISTOPH MIETHKE GMBH & CO. KG.

Additional Manufacturer Narrative · 0

AESCULAP INC. (IMPORTER, REGISTRATION NO. 2916714) IS SUBMITTING THIS REPORT ON BEHALF OF CHRISTOPH MIETHKE GMBH & CO. KG (MANUFACTURER, REGISTRATION NO. 3004721439). EXEMPTION NUMBER: E2017044. WHEN ADDITIONAL INFORMATION IS RECEIVED A FOLLOW UP REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT 2Y 5M PO INFECTION. THE EXPLANTED PRODUCT WERE DELIVERED TO MIETHKE IN DRY AND BLOODY STATE. THE FILE IS ENTERED WITH LIMITED INFORMATION. AN INFECTION OF THE PATIENT WAS THE REASON FOR THE REVISION SURGERY. HEIGHT:175CM.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
202538 PROSA SYS W/PROGAV 2.0 A.CONTROL RESERV. HYDROCEPHALUS MANAGEMENT JXG CHRISTOPH MIETHKE GMBH & CO. KG FX991T UNKNOWN

Patients

Seq Age Sex Outcome Treatment
1 43 YR Required Intervention